v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
May 02, 2026
May 03, 2025
Cash flows from operating activities:    
Net loss $ (15,146) $ (11,661)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 49,041 49,811
Amortization of debt discounts and issuance costs 1,337 1,246
Provision for deferred taxes 288 (9,218)
Equity-based compensation 9,451 9,420
Loss on extinguishment and modification of debt 11,840 0
Income from equity method investees (5,555) (4,610)
Amounts reclassified out of accumulated other comprehensive loss 51 (212)
Non-cash operating lease costs 103,080 102,132
Changes in assets and liabilities:    
Receivables 8,884 4,229
Merchandise inventories (42,702) 7,857
Prepaid expenses and other assets (8,299) (1,673)
Accounts payable and book overdrafts 30,577 (19,028)
Accrued salaries and employee benefits (46,362) (51,130)
Accrued expenses and other liabilities 11,559 12,426
Operating lease liabilities (139,677) (103,780)
Other long-term liabilities 664 (1,263)
Net cash used in operating activities (30,969) (15,454)
Cash flows from investing activities:    
Cash paid for fixed assets (38,153) (28,412)
Insurance recoveries 230 0
Proceeds from sale of assets 0 1,279
Cash received from partial surrender of officers' life insurance 74 0
Net cash used in investing activities (37,849) (27,133)
Cash flows from financing activities:    
Borrowings under long-term debt agreements 1,500,000 0
Repayments of long-term debt (1,500,000) 0
Debt refinancing costs and original issue discount (28,442) 0
Payments for finance lease liabilities (1,110) (1,143)
Proceeds from employee stock purchase plan and stock option exercises 1,008 967
Tax withholdings on stock-based awards (4,094) (158)
Net cash used in financing activities (32,638) (334)
Net decrease in cash, cash equivalents and restricted cash (101,456) (42,921)
Cash, cash equivalents and restricted cash at beginning of period 269,412 181,665
Cash, cash equivalents and restricted cash at end of period 167,956 138,744
Supplemental cash flow disclosure:    
Interest paid, net 21,271 31,112
Supplemental non-cash investing and financing activities disclosure:    
Accounts payable and accrued expenses for capital expenditures $ 17,056 $ 13,010